KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EPIX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

ESSA Pharma Inc. stock upgraded to Sell Candidate.
(Updated on Apr 25, 2024)

Sell candidate since Apr 04, 2024 Loss -25.00% PDF

The ESSA Pharma Inc. stock price fell by -2.08% on the last day (Thursday, 25th Apr 2024) from $6.25 to $6.12. During the last trading day the stock fluctuated 8.56% from a day low at $5.92 to a day high of $6.43. The price has fallen in 7 of the last 10 days and is down by -25.82% for this period. Volume has increased on the last day by 24 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 65 thousand shares were bought and sold for approximately $396.36 thousand.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($6.14) are considered to be a "second chance" to get out. According to the fan-theory $3.82 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EPIX Signals & Forecast

There are few to no technical positive signals at the moment. The ESSA Pharma Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.47 and $8.13. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, February 29, 2024, and so far it has fallen -35.58%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). ESSA Pharma Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for ESSA Pharma Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.507 between high and low, or 8.56%. For the last week, the stock has had daily average volatility of 10.30%.

ESSA Pharma Inc. is oversold on RSI14 (20). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EPIX) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect ESSA Pharma Inc. to open at $6.16, and during the day (based on 14 day Average True Range), to move between $5.49 and $6.75, which gives a possible trading interval of +/-$0.631 (+/-10.31%) up or down from last closing price. If ESSA Pharma Inc. takes out the full calculated possible swing range there will be an estimated 20.61% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $6.32, some $0.200 (3.27%) from the current price of $6.12, our system finds the risk reward not very attractive.

Is ESSA Pharma Inc. stock A Buy?

ESSA Pharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.732 Sell Candidate Upgraded

Predicted Opening Price for ESSA Pharma Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$6.16 ( 0.614%) $6.12

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EPIX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 6.66 8.90 %
R2 6.47 5.74 %
R1 6.35 3.78 %
Current price: 6.12
Support S1 5.96 -2.55 %
S2 5.84 -4.51 %
S3 5.65 -7.67 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 7.30 19.28 %
R2 6.40 4.58 %
R1 6.32 3.27 %
Current price 6.12
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for ESSA Pharma Inc. Stock and on which exchange is it traded?
The symbol for ESSA Pharma Inc. is EPIX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ESSA Pharma Inc. Stock?
ESSA Pharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy ESSA Pharma Inc. Stock?
ESSA Pharma Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ESSA Pharma Inc. Stock.

What's the current price of ESSA Pharma Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an ESSA Pharma Inc. (EPIX) share was $6.12.

What is the 52-week high and low for ESSA Pharma Inc. Stock?
The 52-week high for ESSA Pharma Inc. Stock is $11.67 and the 52-week low is $2.56.

What is the market capitalization of ESSA Pharma Inc. Stock?
As of the Apr 25, 2024, the market capitalization of ESSA Pharma Inc. is 270.737M.

When is the next earnings date for ESSA Pharma Inc.?
The upcoming earnings date for ESSA Pharma Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About ESSA Pharma Inc.

ESSA Pharma. ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and A... EPIX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT